IDH1R132H immunoreactivity in tumor cell components occurred in most WHO II astrocytoma, and sanger sequencing revealed 68.7% (79/115) of WHO II astrocytoma occurred IDH1/2 mutated in our cohorts. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).